Literature DB >> 19395316

IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4.

Sabrina Shandley1, Sonia Martinez, Keith Krolick.   

Abstract

The study reported below describes increased expression of IL-4 receptor in cultured rat myocytes following exposure to an antibody reactive with the acetylcholine receptor (AChR). In addition, upon up-regulation of IL-4R, myocytes demonstrated an increased responsiveness to IL-4 by producing increased levels of IL-15. Moreover, following passive transfer of AChR antibody into Lewis rats, both the increased IL-4R expression and IL-15 production were also observed in intact skeletal muscle, co-localizing in particular individual muscle fibers; the same muscle fibers also produced the chemokine MCP-1 to which IL-4-producing T cells were attracted. A model is proposed in which these muscle activities participate in disease progression in experimental myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395316      PMCID: PMC2735828          DOI: 10.1016/j.clim.2009.03.523

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  41 in total

1.  Interleukin-15 stimulates C2 skeletal myoblast differentiation.

Authors:  L S Quinn; K L Haugk; S E Damon
Journal:  Biochem Biophys Res Commun       Date:  1997-10-09       Impact factor: 3.575

Review 2.  IL-15/IL-15 receptor biology: a guided tour through an expanding universe.

Authors:  Vadim Budagian; Elena Bulanova; Ralf Paus; Silvia Bulfone-Paus
Journal:  Cytokine Growth Factor Rev       Date:  2006-06-30       Impact factor: 7.638

3.  Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats.

Authors:  F D Shi; G X Zhang; X F Bai; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1997-06       Impact factor: 4.330

4.  Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.

Authors:  G X Zhang; B G Xiao; X F Bai; P H van der Meide; A Orn; H Link
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 5.  The IL-4 receptor: signaling mechanisms and biologic functions.

Authors:  K Nelms; A D Keegan; J Zamorano; J J Ryan; W E Paul
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Identification of soluble interleukin-4 receptor in rat glomerular epithelial cells(1).

Authors:  G Chen; R Nagasawa; T Imasawa; Y Eto; K Kikuchi; N Maruyama
Journal:  Biochim Biophys Acta       Date:  1999-10-13

7.  Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.

Authors:  B Balasa; C Deng; J Lee; L M Bradley; D K Dalton; P Christadoss; N Sarvetnick
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

8.  IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection.

Authors:  H Nishimura; K Hiromatsu; N Kobayashi; K H Grabstein; R Paxton; K Sugamura; J A Bluestone; Y Yoshikai
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

9.  Interleukin-15: a novel anabolic cytokine for skeletal muscle.

Authors:  L S Quinn; K L Haugk; K H Grabstein
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.

Authors:  L Moiola; F Galbiati; G Martino; S Amadio; E Brambilla; G Comi; A Vincent; L M Grimaldi; L Adorini
Journal:  Eur J Immunol       Date:  1998-08       Impact factor: 5.532

View more
  5 in total

1.  Serum cytokine and chemokine profiles in patients with myasthenia gravis.

Authors:  A Uzawa; N Kawaguchi; K Himuro; T Kanai; S Kuwabara
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

2.  MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1.

Authors:  Zhuoan Cheng; Shaobo Qiu; Lin Jiang; Anle Zhang; Wenjing Bao; Ping Liu; Jianwen Liu
Journal:  J Clin Immunol       Date:  2012-11-30       Impact factor: 8.317

3.  Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis.

Authors:  Jindrich Soltys; Xiaobo Wu
Journal:  J Inflamm (Lond)       Date:  2012-05-29       Impact factor: 4.981

4.  miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice.

Authors:  Lei Shi; Tiantian Liu; Min Zhang; Yapei Guo; Changdong Song; Dandan Song; Hengfang Liu
Journal:  Med Sci Monit       Date:  2015-06-19

5.  IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population.

Authors:  Ping Jiang; Yao-Xian Yue; Yu Hong; Yanchen Xie; Xiang Gao; Chuan-Kai Gu; Hong-Jun Hao; Yue Qin; Xiao-Jun Ding; Min Song; Hai-Feng Li; Xu Zhang
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.